Literature DB >> 15817996

EGCG, a major component of green tea, inhibits VEGF production by swine granulosa cells.

Giuseppina Basini1, Federico Bianco, Francesca Grasselli.   

Abstract

Vascular Endothelial Growth Factor (VEGF) plays a pivotal role in the physiological ovarian angiogenic process: its production appears to be stimulated by the hypoxic environment which takes place during follicle development. Recently, epigallocatechin-3-gallate (EGCG) from green tea has been used in livestock nutrition as an alternative to antibiotics. However, despite many potential benefits of EGCG consumption, it is also important to get an insight on the possible reproductive-related consequences of feeding supplementation: in fact this substance has been found to inhibit angiogenesis, a process fundamental for follicle development. Therefore, we evaluated the effect of EGCG (5 and 50 microg/ml) on the production of the main angiogenetic factor, VEGF, by swine granulosa cells cultured in normoxia (19% O2), partial (5% O2) or total hypoxia (1% O2). In addition, we studied the effect of the catechin on cell proliferation. Our data demonstrate that both partial and total hypoxia stimulated VEGF production. EGCG reduced VEGF production independently of the O2 condition: 50 microM was the most effective doses. Granulosa cell proliferation was inhibited by EGCG even if only by the highest concentration. This effect might possibly be due to the decrease induced in VEGF production. Therefore feeding supplementation with EGCG should be carefully considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817996     DOI: 10.1002/biof.5520230104

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  5 in total

Review 1.  Green tea polyphenols as proteasome inhibitors: implication in chemoprevention.

Authors:  H Yang; K Landis-Piwowar; T H Chan; Q P Dou
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

2.  Effects of tea polyphenols on ovarian development in rats.

Authors:  L L Luo; J Huang; Y C Fu; J J Xu; Y S Qian
Journal:  J Endocrinol Invest       Date:  2008-12       Impact factor: 4.256

Review 3.  Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma.

Authors:  Chen-Yi Liao; Ching-Chang Lee; Chi-chang Tsai; Chao-Wen Hsueh; Chih-Chiang Wang; I-Hung Chen; Ming-Kai Tsai; Mei-Yu Liu; An-Tie Hsieh; Kuan-Jen Su; Hau-Ming Wu; Shih-Chung Huang; Yi-Chen Wang; Chien-Yao Wang; Shu-Fang Huang; Yen-Cheng Yeh; Ren-Jy Ben; Shang-Tao Chien; Chin-Wen Hsu; Wu-Hsien Kuo
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

4.  Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer.

Authors:  Dongyu Zhang; Hazel B Nichols; Melissa Troester; Jianwen Cai; Jeannette T Bensen; Dale P Sandler
Journal:  Int J Cancer       Date:  2020-02-04       Impact factor: 7.316

5.  Transforming Tea Catechins into Potent Anticancer Compound: Analysis of Three Boronated-PEG Delivery System.

Authors:  Mingyan Guo; Lukas Marek; Yixia Liang; Phei Er Saw
Journal:  Micromachines (Basel)       Date:  2021-12-28       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.